TIL therapy manufacturing infographic
Addressing common challenges at each stage of the workflow.
Explore the workflow – hover over the products to learn more
Related content and resources
Cell therapy services and support at Cytiva
From regulatory support to scientific support, here’s how we can help.
Six misconceptions about cell therapy automation
These misconceptions can potentially hinder the successful execution of an MES for cell therapy.
Cell therapy manufacturing under GMP
It is never too early to start to document processes and gear data collection towards compliance.
Bridging the skills gap in biopharma
As the biopharmaceutical industry continues to grow, the demand for skilled workers increases.
Natural killer cells manufacturing
Here, we describe a workflow that produces primary human NK cells at clinically relevant scale.
CAR T cells: closed and semi-automated processing
A robust workflow that can be adapted for cGMP compliance in commercial production.
Bringing allogeneic cell therapy to patient care
Allogeneic cell therapies are poised to extend the life-changing benefits to many.
Autologous CAR T workflow solutions
Secure your workflow of today—and tomorrow—to get your cell therapy safely to patients.
Cell and gene therapy enterprise solutions
Biomanufacturing platforms and services for cell therapies, plasmids, and viral vectors.
Cryogenics and logistics
Scale with controlled, consistent, and traceable cryopreservation, logistics, and thawing.
Digital manufacturing execution system
Maintain process control when scaling cell therapies.
TIL therapy workflow solutions
Empowering your breakthroughs in tumor-infiltrating lymphocyte (TIL) therapy.
Did you know? Cytiva can support research, development, and manufacturing across a variety of molecules and therapy types.